Clik here to view.
Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in China
LOS ANGELES Targeted Medical Pharma (OTCQB: TRGM), today announced the completion of an exclusive product licensing agreement with Healthy Focus Limited, a Hong Kong based company that specializes...
View ArticleClik here to view.
Pfizer Acquires Treerly and Its Family of Products from Sirio Pharma
SHANGHAI Pfizer Inc. (NYSE:PFE) announced today that it has acquired Sirio Pharma Co. Ltd.’s wholly-owned subsidiary, Treerly Health Co., Ltd., and its family of Treerly products. Treerly is one of...
View ArticleClik here to view.
Astellas Pharma Europe: Lancet Oncology Publishes Results from the Phase 2...
CHERTSEY, England Astellas Pharma Europe Ltd., a subsidiary of Tokyo-based Astellas Pharma Inc. (TSE:4503), today announced that results from the Phase 2 TERRAIN trial of XTANDITM▼ (enzalutamide)...
View ArticleClik here to view.
GEヘルスケアとFedDev Ontarioが、細胞療法の製造上の課題解決に向け、CCRM主導の新センターに4000万カナダドルの提供を約束
英チャルフォントセントジャイルズ & トロント （ビジネスワイヤ） — GEヘルスケアとカナダ連邦オンタリオ州南部経済開発庁（FedDev Ontario）、再生医療商業化センター（CCRM)は、GEおよびFedDev...
View ArticleClik here to view.
胸腹部大動脈瘤の臨床試験で初の植え込みを完了
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、内臓分枝にまたがる大動脈瘤の治療を目的とした臨床試験で、米国初となるGORE® EXCLUDER® Thoracoabdominal Branch...
View ArticleClik here to view.
Genscript Corporation Finishes Year with Successful Hong Kong IPO
PISCATAWAY, N.J. Genscript Biotech Corporation, the number one global provider of gene synthesis services and a strong player in synthetic biology, ended 2015 with a successful IPO of 400,000,000...
View ArticleClik here to view.
Chi-Med initiates HMPL-523 Phase I clinical trial in hematological cancer in...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM: HCM) today announces that Hutchison MediPharma Limited (“HMP”), its drug R&D subsidiary, has initiated a Phase I trial in Australia in...
View ArticleClik here to view.
米国ストラテジア製薬: 富士フイルムの放射免疫療法治療薬FF-21101の進行性がんの患者さんを対象とする第1相臨床試験を開始
ボストン （ビジネスワイヤ） — ストラテジア製薬は、 富士フイルムの子会社 FUJI FILM Pharmaceuticals U.S.A., Inc. (FPHU) の主要な戦略的グローバル医薬品開発プロバイダーとして、進行性がんの患者さんを対象とした放射免疫療法治療薬FF-21101の第1相臨床試験を米国にて開始しました。この臨床試験は、ヴィベック・サビア医師（Vivek...
View ArticleClik here to view.
Samsung Bioepis Enters the European Biopharmaceutical Market with Benepali®,...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a biosimilar referencing Enbrel® (etanercept), also known as SB4 – for the treatment...
View ArticleClik here to view.
Telephus Medical LLC Announces Issuance of Japanese Patent for Anti-MRSA...
SAN DIEGO Telephus Medical LLC (Telephus), a biotechnology company focused on development of antibody therapies for antibiotic-resistant staphylococcal infections, today announced that the Japan...
View ArticleClik here to view.
Hudson Researcher’s Findings May Improve Cancer Drug Clinical Trial Success...
MELBOURNE, Australia A researcher from Hudson Institute of Medical Research in Melbourne, Australia, has discovered a class of biomarkers which may be used to predict which cancer patients will...
View ArticleClik here to view.
AtriCure Announces Approval for the AtriClip in Japan
WEST CHESTER, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received...
View ArticleClik here to view.
MedAdvisor Strengthens Board of Directors with Appointment of Ms Sandra Hook
MELBOURNE, Australia MedAdvisor Limited (ASX:MDR) an Australian software developer focused on improving health outcomes by placing patients at the centre of connected health platforms, today...
View ArticleClik here to view.
Morinaga Milk Opens New Subsidiary in Singapore
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), the leading dairy product company in Japan, today announced the establishment of its new subsidiary, Morinaga Nutritional Foods (Asia Pacific)...
View ArticleClik here to view.
AtriCure宣布 AtriClip在日本获得核准
安大略省西切斯特 (美国商业资讯) — AtriCure, Inc. (Nasdaq: ATRC)是房颤(Afib)治疗和左心耳(LAA)处治领域的领先创新者，该公司今天宣布，其AtriClip™产品（包括AtriClip™标准和AtriClip Pro™器械）已获得日本厚生劳动和福祉省(MHLW)的核准。 AtriCure总裁兼首席执行官Mike...
View ArticleClik here to view.
Cytori Partner Kerastem Expands US Phase II Trial for Early Stage Hair Loss
SAN DIEGO & TOKYO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that its licensee Kerastem Technologies, LLC, has expanded STYLE, its US phase II clinical trial investigating early...
View ArticleClik here to view.
Avera Health Plans “Goes Live” in Record Time with RxAdvance, New Pharmacy...
SOUTHBOROUGH, Mass. Avera Health Plans’ new pharmacy benefit manager (PBM), RxAdvance, today announced record-time implementation of comprehensive, innovative PBM services for the insurer’s members....
View ArticleClik here to view.
European Commission Approves Label Variation for ADCETRIS® (Brentuximab...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the European Commission (EC) has approved a Type II variation for ADCETRIS® (brentuximab...
View ArticleClik here to view.
ViroMed Publishes Results from Critical Limb Ischemia (CLI) Phase II Clinical...
SEOUL, Korea ViroMed Co., Ltd. (KOSDAQ:084990) has announced the publication of the results from successfully completed phase II clinical study of VM202 for the treatment of critical limb ischemia...
View ArticleClik here to view.